id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-2801-0007,FDA,FDA-2017-E-2801,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2019-08-05T04:00:00Z,2019,8,2019-08-05T04:00:00Z,,2019-08-05T12:19:25Z,,0,0,0900006483df1829
FDA-2017-E-2801-0005,FDA,FDA-2017-E-2801,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ASPIRE ASSIST",Notice,Determinations,2018-12-04T05:00:00Z,2018,12,2018-12-04T05:00:00Z,2019-02-05T04:59:59Z,2019-01-30T02:06:05Z,2018-26290,0,0,09000064839394de
FDA-2017-E-2801-0004,FDA,FDA-2017-E-2801,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-11-20T05:00:00Z,2018,11,2018-11-20T05:00:00Z,,2018-11-20T14:25:00Z,,0,0,09000064838ec930
FDA-2017-E-2801-0003,FDA,FDA-2017-E-2801,Letter from U S Patent and Trademark Office,Other,Letter(s),2018-08-16T04:00:00Z,2018,8,2018-08-16T04:00:00Z,,2018-08-16T18:37:26Z,,0,0,090000648362dcc3
FDA-2017-E-2801-0002,FDA,FDA-2017-E-2801,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-10-17T04:00:00Z,2017,10,2017-10-17T04:00:00Z,,2017-10-17T21:20:59Z,,0,0,0900006482bd574d
FDA-2017-E-2801-0001,FDA,FDA-2017-E-2801,"Patent Extension Application fromBaker Hostetler LLP (on behalf of Aspire Bariatrics, LLC)",Other,Application,2017-05-03T04:00:00Z,2017,5,2017-05-03T04:00:00Z,,2017-05-03T15:23:44Z,,0,0,090000648258dda9